Related Experiment Videos
[Results of intensive education and self control in diabetic children and adolescents based on Hb A1c]
Insights
Quarterly glycosylated hemoglobin (Hb A1c) testing is crucial for managing Type I diabetes in young patients. Regular monitoring helps guide therapy and assess prognosis, ensuring better disease control.
Area of Science:
- Pediatric Endocrinology
- Metabolic Disorders
- Diabetes Mellitus Research
Background:
- Type I diabetes mellitus requires continuous management.
- Glycosylated hemoglobin (Hb A1c) is a key indicator of long-term glycemic control.
- Effective monitoring is essential for preventing complications in pediatric patients.
Purpose of the Study:
- To evaluate the utility of Hb A1c measurements in managing Type I diabetes in children and young adults.
- To assess the level of glycemic control in a cohort of young patients.
- To determine the frequency of necessary therapeutic adjustments based on Hb A1c levels.
Main Methods:
- Ninety-six Hb A1c measurements were conducted over 2.25 years.
- The study included 40 children and young adults diagnosed with Type I diabetes mellitus.
- Patient glycemic control was categorized based on Hb A1c results.
Main Results:
- 65% of patients achieved ideal or good glycemic control.
- 17.5% of patients were under satisfactory control.
- 17.5% of patients required urgent therapy readjustment.
Conclusions:
- Quarterly Hb A1c testing is a valuable guideline for diabetes therapy.
- Hb A1c determinations serve as important prognostic and quality control parameters.
- Regular monitoring facilitates timely intervention and improved management of Type I diabetes in youth.
Abstract:
Ninety-six measurements of glycosylated hemoglobin (Hb A1c) were performed over a 2 1/4 year period in 40 children and young adults with Type I diabetes mellitus. Sixty-five per cent of the patients were found to be under ideal or good control and 17.5% under satisfactory control. Urgent readjustment of therapy was indicated in 17.5%. Our experience suggests the importance of quarterly Hb A1c determinations as a therapeutic guide-line and as a prognostic and quality control parameter.